Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56
Published August 17, 2022 · Recall initiated: July 22, 2022
Summary
FDA records drug Class III recall D-1334-2022, published August 17, 2022 and initiated July 22, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 4162 cartons; Lot: Lot: FE22001A, Exp 01/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
What to do
Voluntary: Firm initiated · Letter
Get an email if AZACITIDINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- AZACITIDINE
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Distributed in Ohio
- UPC
- 0368001313568
- Lot
- Lot: FE22001A, Exp 01/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAfentaNYL Citrate in 0.9% Sodium Chloride, 2.5 mg per 250 mL, (10 mcg per mL) IV bags, Rx Only, SterRx, 141August 17, 2022
- FDANatierra Nature & Earth Organic Blueberries Ingredients: Organic Freeze-Dried Blueberries NET WT 12 oz (34g)August 17, 2022
- FDAFentaNYL Citrate in 0.9% Sodium Chloride 1 mg per 100 mL (10 mcg per mL) IV bags, Rx only, SterRx, 141 IdahoAugust 17, 2022
- FDAAzacitidine, 1,00mg/Vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,March 2, 2022
- FDAAzacitidine, 100mg/vial, One Single-dose Vial, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited,March 2, 2022
- FDAAzacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single DoseDecember 16, 2020
Questions about this recall
Was Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56 recalled?
Yes. FDA published recall D-1334-2022 on August 17, 2022. Reported hazard: Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: AZACITIDINE. UPC: 0368001313568.